REXAHN PHARMACEUTICALS, INC.·4

Jun 20, 4:21 PM ET

Kivel Richard 4

4 · REXAHN PHARMACEUTICALS, INC. · Filed Jun 20, 2012

Insider Transaction Report

Form 4
Period: 2012-06-18
Transactions
  • Award

    Stock Options (right-to-buy)

    2012-06-18+20,00020,000 total
    Exercise: $0.38Exp: 2022-06-18Common Stock (20,000 underlying)
Holdings
  • Common Stock

    2,500
  • Stock Options (right-to-buy)

    Exercise: $1.19From: 2011-09-17Exp: 2020-09-17Common Stock (20,000 underlying)
    20,000
  • Stock Options (right-to-buy)

    Exercise: $1.25From: 2012-06-06Exp: 2021-06-06Common Stock (20,000 underlying)
    20,000
Footnotes (1)
  • [F1]These options vest and become exercisable in full on June 18, 2013.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4